Correction: Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induced Neuroinflammation

Correction: Molecular Neurobiology (2023) 61:28-41

https://doi.org/10.1007/s12035-023-03564-9

The original version of this article unfortunately contained error in Figure 1 and the authors would like to correct the image.

Fig. 1

LMP2 expression in the brain is increased upon aging and enhanced in AD mice. a Western blot analysis of cortex and hippocampus LMP2 expression in 14-month-old 5 × FAD and littermate wild-type mice. β-Actin served as a loading control. b Quantifcation of LMP2 protein levels in a, n = 4 mice per group. c Western blot analysis of cortex and hippocampal LMP2 expression in 18-monthold APP/PS1 mice. d Quantifcation of LMP2 protein levels in c, n = 3. e Western blot analysis of LMP2 expression in the cortex and hippocampus of 60-day-, 180-day-, and 480-day-old C57/BL6 mice. f Quantifcation of LMP2 protein levels in e, n = 3 mice per group. g Immunofuorescence of LMP2 expression (red) in the cortex and CA1 region of WT and 5 × FAD mice. Nuclei (blue) visualized by DAPI counterstain. Scale bar 50 μm. h Double immunostaining of LMP2 (red) with IBA1 (green, a microglia specifc protein) or GFAP (green, a astrocyte specifc protein) in the brain of 5 × FAD mice. Data shown are the mean ± SD, *p < 0.05, **p < 0.01, and ***p < 0.001; 180 days vs. 480 days: ##p < 0.01; ns not signifcant

The framed images in Figure 1g, which should have been displayed mice LMP2 expression (red) in the cortex and hippocampus region, but the expression of LMP2^−/−^ rat NLRP3 (red) in the cortex and hippocampus region were mistakenly used.

The corrected images for Figure 1 is hereby published.

The original article has been corrected.